Form 483

Krasnyi Oktyabr Inc Form 483, 2016-04-21

FDA issued a Form 483 to Krasnyi Oktyabr Inc on 2016-04-21 with 7 public-safe observations.

483· Form 483 issuedFoods & Cosmetics7 observations

Krasnyi Oktyabr Inc · Brooklyn, United States · Issued April 21, 2016

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 5 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Apr 2016
21 CFR 123.12(a)(2)

Importer verification

Cited by Jason Kwong, Anthony R Rauert, Onieka T Carpenter, Pasquale L Leone, Rachel E Wapniak

21 Apr 2016
21 CFR 123.6(c)(1)

Food safety hazards

Cited by Jason Kwong, Anthony R Rauert, Onieka T Carpenter, Pasquale L Leone, Rachel E Wapniak

21 Apr 2016
21 CFR 123.6(b)

HACCP plan implementation

Cited by Jason Kwong, Anthony R Rauert, Onieka T Carpenter, Pasquale L Leone, Rachel E Wapniak

21 Apr 2016
21 CFR 123.6(c)(3)

Critical limits

Cited by Jason Kwong, Anthony R Rauert, Onieka T Carpenter, Pasquale L Leone, Rachel E Wapniak

21 Apr 2016
21 CFR 123.6(c)(5)

Corrective action plan

Cited by Jason Kwong, Anthony R Rauert, Onieka T Carpenter, Pasquale L Leone, Rachel E Wapniak

Inspected site

KOKrasnyi Oktyabr IncBrooklyn, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 123.12(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 123.6(b)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(1)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(3)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(5)Cited across public-safe Form 483 observations1x
21 CFR 123.6(c)(6)Cited across public-safe Form 483 observations1x
21 CFR 123.6(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere